English

Oncologix Tech Inc.

EDGAR

Current report (8-K) · filed 2016-12-30

128 filing records in this dataset, filed from 1996-02-02 to 2016-12-30. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.24 million USD

2015 Q3 · USD

Exact inputs and evidence

Revenue: 1235656 USD Source

Operating margin

-8%

2015 Q3 · %

Exact inputs and evidence

Operating Income: -98851 USD Source
Revenue: 1235656 USD Source

Operating cash flow

-28.1 thousand USD

2015 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -390970 USD Source
Operating Cash Flow: -362869 USD Source

Cash and cash equivalents: 120 thousand USD 2015-05-31 Source
Exact value

120485 USD
Long-term debt including current maturities: Not available
Shares outstanding: 277 million shares 2015-05-31 Source
Exact value

276746130 shares

Reported share-count change

138.17% · 161 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

116195217 shares · 2014-05-31· Source
276746130 shares · 2015-05-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.61 million USD

2014-06-01 – 2015-05-31

Exact inputs and evidence

Revenue: 3677475 USD · 2013-09-01 – 2014-08-31 Source
Revenue: 2696776 USD · 2013-09-01 – 2014-05-31 Source
Revenue: 1161874 USD · 2014-09-01 – 2014-11-30 Source
Revenue: 1227877 USD · 2014-12-01 – 2015-02-28 Source
Revenue: 1235656 USD · 2015-03-01 – 2015-05-31 Source

Net income

-1.57 million USD

2013-12-01 – 2014-11-30

Exact inputs and evidence

Net income: -817915 USD · 2013-09-01 – 2014-02-28 Source
Net income: -189829 USD · 2013-09-01 – 2013-11-30 Source
Net income: -1056865 USD · 2013-09-01 – 2014-05-31 Source
Net income: -817915 USD · 2013-09-01 – 2014-02-28 Source
Net income: -1312043 USD · 2013-09-01 – 2014-08-31 Source
Net income: -1056865 USD · 2013-09-01 – 2014-05-31 Source
Net income: -443289 USD · 2014-09-01 – 2014-11-30 Source

Operating cash flow

-570 thousand USD

2014-06-01 – 2015-05-31

Exact inputs and evidence

Operating cash flow: -629942 USD · 2013-09-01 – 2014-08-31 Source
Operating cash flow: -450662 USD · 2013-09-01 – 2014-05-31 Source
Operating cash flow: -195901 USD · 2014-09-01 – 2014-11-30 Source
Operating cash flow: -362869 USD · 2014-09-01 – 2015-02-28 Source
Operating cash flow: -195901 USD · 2014-09-01 – 2014-11-30 Source
Operating cash flow: -390970 USD · 2014-09-01 – 2015-05-31 Source
Operating cash flow: -362869 USD · 2014-09-01 – 2015-02-28 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-12-30.

Financial data available through: 2014-08-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2014-08-31
Operating income: 11 of 11 periods available· newest 2014-08-31
Net income: 11 of 11 periods available· newest 2014-08-31
Operating cash flow: 11 of 11 periods available· newest 2014-08-31
Capital expenditure: 11 of 11 periods available· newest 2014-08-31
Total assets: 9 of 11 periods available· newest 2014-08-31
Total liabilities: 9 of 11 periods available· newest 2014-08-31
Current assets: 9 of 11 periods available· newest 2014-08-31
Current liabilities: 9 of 11 periods available· newest 2014-08-31
Cash and cash equivalents: 9 of 11 periods available· newest 2014-08-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2014-08-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+1,405.6%

Prior period

USD 244,246

2012-09-01 – 2013-08-31
Current period

USD 3.68 million

2013-09-01 – 2014-08-31

Exact inputs and evidence

3677475 − 244246 = 3433229 USD

244246 USD · 2012-09-01 – 2013-08-31
Inspect prior input Prior source
3677475 USD · 2013-09-01 – 2014-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Oncologix Tech Inc. · 2014-08-31 Oncologix Tech Inc. (edgar:799694) Year-over-year change in Revenue: 3433229 USD Concept: fundies:Revenue Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3677475 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#223359 Filing: 000147124214000418 Input fundies:Revenue: 244246 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#223244 Filing: 000147124214000418
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 658,584

Prior period

−USD 653,459

2012-09-01 – 2013-08-31
Current period

−USD 1.31 million

2013-09-01 – 2014-08-31

Exact inputs and evidence

-1312043 − -653459 = -658584 USD

-653459 USD · 2012-09-01 – 2013-08-31
Inspect prior input Prior source
-1312043 USD · 2013-09-01 – 2014-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Oncologix Tech Inc. · 2014-08-31 Oncologix Tech Inc. (edgar:799694) Year-over-year change in Net income: -658584 USD Concept: fundies:NetIncome Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1312043 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#645720 Filing: 000147124214000418 Input fundies:NetIncome: -653459 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#645594 Filing: 000147124214000418
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 524,125

Prior period

−USD 105,817

2012-09-01 – 2013-08-31
Current period

−USD 629,942

2013-09-01 – 2014-08-31

Exact inputs and evidence

-629942 − -105817 = -524125 USD

-105817 USD · 2012-09-01 – 2013-08-31
Inspect prior input Prior source
-629942 USD · 2013-09-01 – 2014-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Oncologix Tech Inc. · 2014-08-31 Oncologix Tech Inc. (edgar:799694) Year-over-year change in Operating cash flow: -524125 USD Concept: fundies:OperatingCashFlow Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -629942 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#652657 Filing: 000147124214000418 Input fundies:OperatingCashFlow: -105817 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#652473 Filing: 000147124214000418
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2013-09-01 – 2014-08-31

Revenue USD 3.68 million 100% of revenue
Cost of revenue USD 3.06 million 83% of revenue
Operating expenses USD 1.19 million 32% of revenue
Operating income −USD 571,839 −16% of revenue
Tax, interest and other Derived USD 740,204 20% of revenue
Net income −USD 1.31 million −36% of revenue

Cash

Operating cash flow −USD 629,942 −17% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Operating loss: operating costs were 594% of revenue.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.
2011 Not shown: operating income or net income is not reported.
2013 Operating loss: operating costs were 217% of revenue.
2014 Operating loss: operating costs were 116% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2005-09-01 – 2006-08-31	1174073	6976767 Derived	-5802694	283371 Derived	-6086065	-560845 Derived	Source 2005-09-01 – 2006-08-31: 1174073 USD Inspect Revenue Open source 2005-09-01 – 2006-08-31: -5802694 USD Inspect Operating Income Open source 2005-09-01 – 2006-08-31: -6086065 USD Inspect Net Income Open source 2005-09-01 – 2006-08-31: -555788 USD Inspect Operating Cash Flow Open source 2005-09-01 – 2006-08-31: 5057 USD Inspect Capital Expenditure Open source
2008 2007-09-01 – 2008-08-31	0	590245 Derived	-590245	4000568 Derived	-4590813	-1297308 Derived	Source 2007-09-01 – 2008-08-31: 0 USD Inspect Revenue Open source 2007-09-01 – 2008-08-31: -590245 USD Inspect Operating Income Open source 2007-09-01 – 2008-08-31: -4590813 USD Inspect Net Income Open source 2007-09-01 – 2008-08-31: -1297308 USD Inspect Operating Cash Flow Open source 2007-09-01 – 2008-08-31: 0 USD Inspect Capital Expenditure Open source
2009 2008-09-01 – 2009-08-31	0	359885 Derived	-359885	2215247 Derived	-2575132	-130816 Derived	Source 2008-09-01 – 2009-08-31: 0 USD Inspect Revenue Open source 2008-09-01 – 2009-08-31: -359885 USD Inspect Operating Income Open source 2008-09-01 – 2009-08-31: -2575132 USD Inspect Net Income Open source 2008-09-01 – 2009-08-31: -130816 USD Inspect Operating Cash Flow Open source 2008-09-01 – 2009-08-31: 0 USD Inspect Capital Expenditure Open source
2010 2009-09-01 – 2010-08-31	0	192074 Derived	-192074	551124 Derived	-743198	-227917 Derived	Source 2009-09-01 – 2010-08-31: 0 USD Inspect Revenue Open source 2009-09-01 – 2010-08-31: -192074 USD Inspect Operating Income Open source 2009-09-01 – 2010-08-31: -743198 USD Inspect Net Income Open source 2009-09-01 – 2010-08-31: -227349 USD Inspect Operating Cash Flow Open source 2009-09-01 – 2010-08-31: 568 USD Inspect Capital Expenditure Open source
2011 2010-09-01 – 2011-08-31	0	196538 Derived	-196538	39071 Derived	-235609	-178538 Derived	Source 2010-09-01 – 2011-08-31: 0 USD Inspect Revenue Open source 2010-09-01 – 2011-08-31: -196538 USD Inspect Operating Income Open source 2010-09-01 – 2011-08-31: -235609 USD Inspect Net Income Open source 2010-09-01 – 2011-08-31: -178538 USD Inspect Operating Cash Flow Open source 2010-09-01 – 2011-08-31: 0 USD Inspect Capital Expenditure Open source
2013 2012-09-01 – 2013-08-31	244246	530821 Derived	-286575	366884 Derived	-653459	Unavailable	Source 2012-09-01 – 2013-08-31: 244246 USD Inspect Revenue Open source 2012-09-01 – 2013-08-31: -286575 USD Inspect Operating Income Open source 2012-09-01 – 2013-08-31: -653459 USD Inspect Net Income Open source 2012-09-01 – 2013-08-31: -105817 USD Inspect Operating Cash Flow Open source
2014 2013-09-01 – 2014-08-31	3677475	4249314 Derived	-571839	740204 Derived	-1312043	Unavailable	Source 2013-09-01 – 2014-08-31: 3677475 USD Inspect Revenue Open source 2013-09-01 – 2014-08-31: -571839 USD Inspect Operating Income Open source 2013-09-01 – 2014-08-31: -1312043 USD Inspect Net Income Open source 2013-09-01 – 2014-08-31: -629942 USD Inspect Operating Cash Flow Open source 2013-09-01 – 2014-08-31: -878 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.7M 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-08-31	Revenue	2150626	Revenue: 2150626 Open source
20052005-08-31	Revenue	1546302	Revenue: 1546302 Open source
20062006-08-31	Revenue	1174073	Revenue: 1174073 Open source
20082008-08-31	Revenue	0	Revenue: 0 Open source
20092009-08-31	Revenue	0	Revenue: 0 Open source
20102010-08-31	Revenue	0	Revenue: 0 Open source
20112011-08-31	Revenue	0	Revenue: 0 Open source
20132013-08-31	Revenue	244246	Revenue: 244246 Open source
20142014-08-31	Revenue	3677475	Revenue: 3677475 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

1,405.6% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-08-31	Year over year	No prior comparable period	Revenue: 2150626 Open source
20052005-08-31	Year over year	-28.1%	Revenue: 1546302 Open source Revenue: 2150626 Open source
20062006-08-31	Year over year	-24.1%	Revenue: 1174073 Open source Revenue: 1546302 Open source
20082008-08-31	Year over year	No prior comparable period	Revenue: 0 Open source
20092009-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20112011-08-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20132013-08-31	Year over year	No prior comparable period	Revenue: 244246 Open source
20142014-08-31	Year over year	1,405.6%	Revenue: 3677475 Open source Revenue: 244246 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -15.5% 2014

Net margin -35.7% 2014

Free cash flow margin -47.8% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2004-08-31	Operating margin	Not reported	Revenue: 2150626 Open source
20052005-08-31	Operating margin	-48.7%	Operating Income: -753069 Open source Revenue: 1546302 Open source
20062006-08-31	Operating margin	-494.2%	Operating Income: -5802694 Open source Revenue: 1174073 Open source
20082008-08-31	Operating margin	Not reported	Operating Income: -590245 Open source Revenue: 0 Open source
20092009-08-31	Operating margin	Not reported	Operating Income: -359885 Open source Revenue: 0 Open source
20102010-08-31	Operating margin	Not reported	Operating Income: -192074 Open source Revenue: 0 Open source
20112011-08-31	Operating margin	Not reported	Operating Income: -196538 Open source Revenue: 0 Open source
20132013-08-31	Operating margin	-117.3%	Operating Income: -286575 Open source Revenue: 244246 Open source
20142014-08-31	Operating margin	-15.5%	Operating Income: -571839 Open source Revenue: 3677475 Open source
2004-08-31	Net margin	Not reported	Revenue: 2150626 Open source
20052005-08-31	Net margin	-50.1%	Net Income: -774112 Open source Revenue: 1546302 Open source
20062006-08-31	Net margin	-518.4%	Net Income: -6086065 Open source Revenue: 1174073 Open source
20082008-08-31	Net margin	Not reported	Net Income: -4590813 Open source Revenue: 0 Open source
20092009-08-31	Net margin	Not reported	Net Income: -2575132 Open source Revenue: 0 Open source
20102010-08-31	Net margin	Not reported	Net Income: -743198 Open source Revenue: 0 Open source
20112011-08-31	Net margin	Not reported	Net Income: -235609 Open source Revenue: 0 Open source
20132013-08-31	Net margin	-267.5%	Net Income: -653459 Open source Revenue: 244246 Open source
20142014-08-31	Net margin	-35.7%	Net Income: -1312043 Open source Revenue: 3677475 Open source
20042004-08-31	Free cash flow margin	Not reported	Revenue: 2150626 Open source
20052005-08-31	Free cash flow margin	Not reported	Revenue: 1546302 Open source
20062006-08-31	Free cash flow margin	-47.8%	Revenue: 1174073 Open source Operating Cash Flow: -555788 Open source Capital Expenditure: 5057 Open source
20082008-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1297308 Open source Capital Expenditure: 0 Open source
20092009-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -130816 Open source Capital Expenditure: 0 Open source
20102010-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -227349 Open source Capital Expenditure: 568 Open source
20112011-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -178538 Open source Capital Expenditure: 0 Open source
20132013-08-31	Free cash flow margin	Not reported	Revenue: 244246 Open source Operating Cash Flow: -105817 Open source
20142014-08-31	Free cash flow margin	Not reported	Revenue: 3677475 Open source Operating Cash Flow: -629942 Open source Capital Expenditure: -878 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -629.9K 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-08-31	Operating cash flow	Not reported	No source recorded
20052005-08-31	Operating cash flow	Not reported	No source recorded
20062006-08-31	Operating cash flow	-555788	Operating Cash Flow: -555788 Open source
20082008-08-31	Operating cash flow	-1297308	Operating Cash Flow: -1297308 Open source
20092009-08-31	Operating cash flow	-130816	Operating Cash Flow: -130816 Open source
20102010-08-31	Operating cash flow	-227349	Operating Cash Flow: -227349 Open source
20112011-08-31	Operating cash flow	-178538	Operating Cash Flow: -178538 Open source
20132013-08-31	Operating cash flow	-105817	Operating Cash Flow: -105817 Open source
20142014-08-31	Operating cash flow	-629942	Operating Cash Flow: -629942 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -178.5K 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-08-31	Free cash flow	Unavailable	No source recorded
20052005-08-31	Free cash flow	Unavailable	No source recorded
20062006-08-31	Free cash flow	-560845	Operating Cash Flow: -555788 Open source Capital Expenditure: 5057 Open source
20082008-08-31	Free cash flow	-1297308	Operating Cash Flow: -1297308 Open source Capital Expenditure: 0 Open source
20092009-08-31	Free cash flow	-130816	Operating Cash Flow: -130816 Open source Capital Expenditure: 0 Open source
20102010-08-31	Free cash flow	-227917	Operating Cash Flow: -227349 Open source Capital Expenditure: 568 Open source
20112011-08-31	Free cash flow	-178538	Operating Cash Flow: -178538 Open source Capital Expenditure: 0 Open source
20132013-08-31	Free cash flow	Unavailable	Operating Cash Flow: -105817 Open source
20142014-08-31	Free cash flow	Unavailable	Operating Cash Flow: -629942 Open source Capital Expenditure: -878 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

131.1% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20042004-08-31	Liabilities / assets	49.3%	Total Liabilities: 455719 Open source Total Assets: 923691 Open source
20052005-08-31	Liabilities / assets	43.4%	Total Liabilities: 199179 Open source Total Assets: 458967 Open source
20062006-08-31	Liabilities / assets	190%	Total Liabilities: 1270783 Open source Total Assets: 668955 Open source
20082008-08-31	Liabilities / assets	1,138.5%	Total Liabilities: 2736104 Open source Total Assets: 240317 Open source
20092009-08-31	Liabilities / assets	8,581.2%	Total Liabilities: 1838783 Open source Total Assets: 21428 Open source
20102010-08-31	Liabilities / assets	3,309.1%	Total Liabilities: 615292 Open source Total Assets: 18594 Open source
20112011-08-31	Liabilities / assets	4,309.5%	Total Liabilities: 662418 Open source Total Assets: 15371 Open source
20132013-08-31	Liabilities / assets	117.7%	Total Liabilities: 2394595 Open source Total Assets: 2033850 Open source
20142014-08-31	Liabilities / assets	131.1%	Total Liabilities: 2800176 Open source Total Assets: 2135458 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.11× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-08-31	Current assets / current liabilities	1.15×	Current Assets: 521786 Open source Current Liabilities: 452998 Open source
20052005-08-31	Current assets / current liabilities	0.86×	Current Assets: 170471 Open source Current Liabilities: 199179 Open source
20062006-08-31	Current assets / current liabilities	0.36×	Current Assets: 462015 Open source Current Liabilities: 1270783 Open source
20082008-08-31	Current assets / current liabilities	0.05×	Current Assets: 92082 Open source Current Liabilities: 1925316 Open source
20092009-08-31	Current assets / current liabilities	0.01×	Current Assets: 10526 Open source Current Liabilities: 1476046 Open source
20102010-08-31	Current assets / current liabilities	0.07×	Current Assets: 16759 Open source Current Liabilities: 252555 Open source
20112011-08-31	Current assets / current liabilities	0.02×	Current Assets: 15007 Open source Current Liabilities: 662418 Open source
20132013-08-31	Current assets / current liabilities	0.14×	Current Assets: 218222 Open source Current Liabilities: 1583095 Open source
20142014-08-31	Current assets / current liabilities	0.11×	Current Assets: 274633 Open source Current Liabilities: 2404501 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2005-09-01 – 2006-08-31	−USD 6.09 million Exact value Exact value: -6086065 USD 2005-09-01 – 2006-08-31: -6086065 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2006-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -6086065 USD Concept: fundies:NetIncome Period: 2005-09-01 to 2006-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2006-08-31&surface=latest&period_type=duration&start=2005-09-01&unit=USD&dimensions= Input fundies:NetIncome: -6086065 USD (2005-09-01 to 2006-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-07-000383.txt#2991 The citation records this snapshot. The page link may show a newer release later.	−USD 555,788 Exact value Exact value: -555788 USD 2005-09-01 – 2006-08-31: -555788 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2006-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -555788 USD Concept: fundies:OperatingCashFlow Period: 2005-09-01 to 2006-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2006-08-31&surface=latest&period_type=duration&start=2005-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -555788 USD (2005-09-01 to 2006-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-07-000383.txt#3014 The citation records this snapshot. The page link may show a newer release later.	USD 5,057 Exact value Exact value: 5057 USD 2005-09-01 – 2006-08-31: 5057 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oncologix Tech Inc. · 2006-08-31 Oncologix Tech Inc. (edgar:799694) Capital Expenditure: 5057 USD Concept: fundies:CapitalExpenditure Period: 2005-09-01 to 2006-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ACapitalExpenditure&period=2006-08-31&surface=latest&period_type=duration&start=2005-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5057 USD (2005-09-01 to 2006-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-07-000383.txt#3019 The citation records this snapshot. The page link may show a newer release later.	−USD 560,845 Calculation and evidence -555788 − 5057 USD Exact free cash flow: -560845 USD 2005-09-01 – 2006-08-31: -555788 USD · Inspect Operating Cash Flow · Source 2005-09-01 – 2006-08-31: 5057 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oncologix Tech Inc. · 2006-08-31 Oncologix Tech Inc. (edgar:799694) Free cash flow: -560845 USD Concept: free-cash-flow Period: 2005-09-01 to 2006-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -555788 USD (2005-09-01 to 2006-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-07-000383.txt#3014 Input fundies:CapitalExpenditure: 5057 USD (2005-09-01 to 2006-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-07-000383.txt#3019 The citation records this snapshot. The page link may show a newer release later.
2007 2006-09-01 – 2007-08-31	−USD 7.65 million Exact value Exact value: -7646212 USD 2006-09-01 – 2007-08-31: -7646212 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2007-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -7646212 USD Concept: fundies:NetIncome Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2007-08-31&surface=latest&period_type=duration&start=2006-09-01&unit=USD&dimensions= Input fundies:NetIncome: -7646212 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-09-000166.txt#1919 The citation records this snapshot. The page link may show a newer release later.	−USD 3.08 million Exact value Exact value: -3080529 USD 2006-09-01 – 2007-08-31: -3080529 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2007-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -3080529 USD Concept: fundies:OperatingCashFlow Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2007-08-31&surface=latest&period_type=duration&start=2006-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3080529 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-09-000166.txt#1945 The citation records this snapshot. The page link may show a newer release later.	USD 2,882 Exact value Exact value: 2882 USD 2006-09-01 – 2007-08-31: 2882 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oncologix Tech Inc. · 2007-08-31 Oncologix Tech Inc. (edgar:799694) Capital Expenditure: 2882 USD Concept: fundies:CapitalExpenditure Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ACapitalExpenditure&period=2007-08-31&surface=latest&period_type=duration&start=2006-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2882 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-09-000166.txt#1950 The citation records this snapshot. The page link may show a newer release later.	−USD 3.08 million Calculation and evidence -3080529 − 2882 USD Exact free cash flow: -3083411 USD 2006-09-01 – 2007-08-31: -3080529 USD · Inspect Operating Cash Flow · Source 2006-09-01 – 2007-08-31: 2882 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oncologix Tech Inc. · 2007-08-31 Oncologix Tech Inc. (edgar:799694) Free cash flow: -3083411 USD Concept: free-cash-flow Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3080529 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-09-000166.txt#1945 Input fundies:CapitalExpenditure: 2882 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-09-000166.txt#1950 The citation records this snapshot. The page link may show a newer release later.
2008 2007-09-01 – 2008-08-31	−USD 4.59 million Exact value Exact value: -4590813 USD 2007-09-01 – 2008-08-31: -4590813 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2008-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -4590813 USD Concept: fundies:NetIncome Period: 2007-09-01 to 2008-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2008-08-31&surface=latest&period_type=duration&start=2007-09-01&unit=USD&dimensions= Input fundies:NetIncome: -4590813 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-10-000025.txt#1684 The citation records this snapshot. The page link may show a newer release later.	−USD 1.3 million Exact value Exact value: -1297308 USD 2007-09-01 – 2008-08-31: -1297308 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2008-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -1297308 USD Concept: fundies:OperatingCashFlow Period: 2007-09-01 to 2008-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2008-08-31&surface=latest&period_type=duration&start=2007-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1297308 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-10-000025.txt#1875 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2007-09-01 – 2008-08-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oncologix Tech Inc. · 2008-08-31 Oncologix Tech Inc. (edgar:799694) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2007-09-01 to 2008-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ACapitalExpenditure&period=2008-08-31&surface=latest&period_type=duration&start=2007-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-09-000166.txt#1950 The citation records this snapshot. The page link may show a newer release later.	−USD 1.3 million Calculation and evidence -1297308 − 0 USD Exact free cash flow: -1297308 USD 2007-09-01 – 2008-08-31: -1297308 USD · Inspect Operating Cash Flow · Source 2007-09-01 – 2008-08-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oncologix Tech Inc. · 2008-08-31 Oncologix Tech Inc. (edgar:799694) Free cash flow: -1297308 USD Concept: free-cash-flow Period: 2007-09-01 to 2008-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1297308 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-10-000025.txt#1875 Input fundies:CapitalExpenditure: 0 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001108890-09-000166.txt#1950 The citation records this snapshot. The page link may show a newer release later.
2009 2008-09-01 – 2009-08-31	−USD 2.58 million Exact value Exact value: -2575132 USD 2008-09-01 – 2009-08-31: -2575132 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2009-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -2575132 USD Concept: fundies:NetIncome Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2009-08-31&surface=latest&period_type=duration&start=2008-09-01&unit=USD&dimensions= Input fundies:NetIncome: -2575132 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000044.txt#4744 The citation records this snapshot. The page link may show a newer release later.	−USD 130,816 Exact value Exact value: -130816 USD 2008-09-01 – 2009-08-31: -130816 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2009-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -130816 USD Concept: fundies:OperatingCashFlow Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2009-08-31&surface=latest&period_type=duration&start=2008-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -130816 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000044.txt#6640 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2008-09-01 – 2009-08-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oncologix Tech Inc. · 2009-08-31 Oncologix Tech Inc. (edgar:799694) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ACapitalExpenditure&period=2009-08-31&surface=latest&period_type=duration&start=2008-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000044.txt#6674 The citation records this snapshot. The page link may show a newer release later.	−USD 130,816 Calculation and evidence -130816 − 0 USD Exact free cash flow: -130816 USD 2008-09-01 – 2009-08-31: -130816 USD · Inspect Operating Cash Flow · Source 2008-09-01 – 2009-08-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oncologix Tech Inc. · 2009-08-31 Oncologix Tech Inc. (edgar:799694) Free cash flow: -130816 USD Concept: free-cash-flow Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -130816 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000044.txt#6640 Input fundies:CapitalExpenditure: 0 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000044.txt#6674 The citation records this snapshot. The page link may show a newer release later.
2010 2009-09-01 – 2010-08-31	−USD 743,198 Exact value Exact value: -743198 USD 2009-09-01 – 2010-08-31: -743198 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2010-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -743198 USD Concept: fundies:NetIncome Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2010-08-31&surface=latest&period_type=duration&start=2009-09-01&unit=USD&dimensions= Input fundies:NetIncome: -743198 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000298.txt#2443 The citation records this snapshot. The page link may show a newer release later.	−USD 227,349 Exact value Exact value: -227349 USD 2009-09-01 – 2010-08-31: -227349 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2010-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -227349 USD Concept: fundies:OperatingCashFlow Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2010-08-31&surface=latest&period_type=duration&start=2009-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -227349 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000298.txt#3126 The citation records this snapshot. The page link may show a newer release later.	USD 568 Exact value Exact value: 568 USD 2009-09-01 – 2010-08-31: 568 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oncologix Tech Inc. · 2010-08-31 Oncologix Tech Inc. (edgar:799694) Capital Expenditure: 568 USD Concept: fundies:CapitalExpenditure Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ACapitalExpenditure&period=2010-08-31&surface=latest&period_type=duration&start=2009-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 568 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000298.txt#3141 The citation records this snapshot. The page link may show a newer release later.	−USD 227,917 Calculation and evidence -227349 − 568 USD Exact free cash flow: -227917 USD 2009-09-01 – 2010-08-31: -227349 USD · Inspect Operating Cash Flow · Source 2009-09-01 – 2010-08-31: 568 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oncologix Tech Inc. · 2010-08-31 Oncologix Tech Inc. (edgar:799694) Free cash flow: -227917 USD Concept: free-cash-flow Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -227349 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000298.txt#3126 Input fundies:CapitalExpenditure: 568 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000298.txt#3141 The citation records this snapshot. The page link may show a newer release later.
2011 2010-09-01 – 2011-08-31	−USD 235,609 Exact value Exact value: -235609 USD 2010-09-01 – 2011-08-31: -235609 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2011-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -235609 USD Concept: fundies:NetIncome Period: 2010-09-01 to 2011-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2011-08-31&surface=latest&period_type=duration&start=2010-09-01&unit=USD&dimensions= Input fundies:NetIncome: -235609 USD (2010-09-01 to 2011-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000100009612000185/oclg-20120831.xml#45046 Filing: 000100009612000185 The citation records this snapshot. The page link may show a newer release later.	−USD 178,538 Exact value Exact value: -178538 USD 2010-09-01 – 2011-08-31: -178538 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2011-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -178538 USD Concept: fundies:OperatingCashFlow Period: 2010-09-01 to 2011-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2011-08-31&surface=latest&period_type=duration&start=2010-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -178538 USD (2010-09-01 to 2011-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000100009612000185/oclg-20120831.xml#307730 Filing: 000100009612000185 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2010-09-01 – 2011-08-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oncologix Tech Inc. · 2011-08-31 Oncologix Tech Inc. (edgar:799694) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2010-09-01 to 2011-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ACapitalExpenditure&period=2011-08-31&surface=latest&period_type=duration&start=2010-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2010-09-01 to 2011-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000298.txt#3141 The citation records this snapshot. The page link may show a newer release later.	−USD 178,538 Calculation and evidence -178538 − 0 USD Exact free cash flow: -178538 USD 2010-09-01 – 2011-08-31: -178538 USD · Inspect Operating Cash Flow · Source 2010-09-01 – 2011-08-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oncologix Tech Inc. · 2011-08-31 Oncologix Tech Inc. (edgar:799694) Free cash flow: -178538 USD Concept: free-cash-flow Period: 2010-09-01 to 2011-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -178538 USD (2010-09-01 to 2011-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000100009612000185/oclg-20120831.xml#307730 Filing: 000100009612000185 Input fundies:CapitalExpenditure: 0 USD (2010-09-01 to 2011-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/0001000096-11-000298.txt#3141 The citation records this snapshot. The page link may show a newer release later.
2012 2011-06-01 – 2012-05-31	−USD 272,469 Exact value Exact value: -272469 USD 2011-06-01 – 2012-05-31: -272469 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2012-05-31 Oncologix Tech Inc. (edgar:799694) Net Income: -272469 USD Concept: fundies:NetIncome Period: 2011-06-01 to 2012-05-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2012-05-31&surface=latest&period_type=duration&start=2011-06-01&unit=USD&dimensions= Input fundies:NetIncome: -272469 USD (2011-06-01 to 2012-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124212000951/oclg-20120531.xml#25563 Filing: 000147124212000951 The citation records this snapshot. The page link may show a newer release later.	−USD 158,044 Exact value Exact value: -158044 USD 2011-06-01 – 2012-05-31: -158044 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2012-05-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -158044 USD Concept: fundies:OperatingCashFlow Period: 2011-06-01 to 2012-05-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2012-05-31&surface=latest&period_type=duration&start=2011-06-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -158044 USD (2011-06-01 to 2012-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124212000951/oclg-20120531.xml#28925 Filing: 000147124212000951 The citation records this snapshot. The page link may show a newer release later.	USD 1,289 Exact value Exact value: 1289 USD 2011-06-01 – 2012-05-31: 1289 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Oncologix Tech Inc. · 2012-05-31 Oncologix Tech Inc. (edgar:799694) Capital Expenditure: 1289 USD Concept: fundies:CapitalExpenditure Period: 2011-06-01 to 2012-05-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ACapitalExpenditure&period=2012-05-31&surface=latest&period_type=duration&start=2011-06-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1289 USD (2011-06-01 to 2012-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124212000951/oclg-20120531.xml#29470 Filing: 000147124212000951 The citation records this snapshot. The page link may show a newer release later.	−USD 159,333 Calculation and evidence -158044 − 1289 USD Exact free cash flow: -159333 USD 2011-06-01 – 2012-05-31: -158044 USD · Inspect Operating Cash Flow · Source 2011-06-01 – 2012-05-31: 1289 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Oncologix Tech Inc. · 2012-05-31 Oncologix Tech Inc. (edgar:799694) Free cash flow: -159333 USD Concept: free-cash-flow Period: 2011-06-01 to 2012-05-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -158044 USD (2011-06-01 to 2012-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124212000951/oclg-20120531.xml#28925 Filing: 000147124212000951 Input fundies:CapitalExpenditure: 1289 USD (2011-06-01 to 2012-05-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124212000951/oclg-20120531.xml#29470 Filing: 000147124212000951 The citation records this snapshot. The page link may show a newer release later.
2012 2011-09-01 – 2012-08-31	−USD 285,569 Exact value Exact value: -285569 USD 2011-09-01 – 2012-08-31: -285569 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2012-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -285569 USD Concept: fundies:NetIncome Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2012-08-31&surface=latest&period_type=duration&start=2011-09-01&unit=USD&dimensions= Input fundies:NetIncome: -285569 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000362/oclg-20130831.xml#169907 Filing: 000147124214000362 The citation records this snapshot. The page link may show a newer release later.	−USD 119,381 Exact value Exact value: -119381 USD 2011-09-01 – 2012-08-31: -119381 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2012-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -119381 USD Concept: fundies:OperatingCashFlow Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2012-08-31&surface=latest&period_type=duration&start=2011-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -119381 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000362/oclg-20130831.xml#177901 Filing: 000147124214000362 The citation records this snapshot. The page link may show a newer release later.	Unavailable The mapped spending value is negative, so its direction is unclear. Source Inspect Capital Expenditure Open source	Unavailable Capital expenditure has a negative mapped value; spending direction is unclear.
2013 2012-09-01 – 2013-08-31	−USD 653,459 Exact value Exact value: -653459 USD 2012-09-01 – 2013-08-31: -653459 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2013-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -653459 USD Concept: fundies:NetIncome Period: 2012-09-01 to 2013-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2013-08-31&surface=latest&period_type=duration&start=2012-09-01&unit=USD&dimensions= Input fundies:NetIncome: -653459 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#645594 Filing: 000147124214000418 The citation records this snapshot. The page link may show a newer release later.	−USD 105,817 Exact value Exact value: -105817 USD 2012-09-01 – 2013-08-31: -105817 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2013-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -105817 USD Concept: fundies:OperatingCashFlow Period: 2012-09-01 to 2013-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2013-08-31&surface=latest&period_type=duration&start=2012-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -105817 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#652473 Filing: 000147124214000418 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-09-01 – 2014-08-31	−USD 1.31 million Exact value Exact value: -1312043 USD 2013-09-01 – 2014-08-31: -1312043 USD Inspect Net Income Open source Share or cite Citation for Net Income · Oncologix Tech Inc. · 2014-08-31 Oncologix Tech Inc. (edgar:799694) Net Income: -1312043 USD Concept: fundies:NetIncome Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3ANetIncome&period=2014-08-31&surface=latest&period_type=duration&start=2013-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1312043 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#645720 Filing: 000147124214000418 The citation records this snapshot. The page link may show a newer release later.	−USD 629,942 Exact value Exact value: -629942 USD 2013-09-01 – 2014-08-31: -629942 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Oncologix Tech Inc. · 2014-08-31 Oncologix Tech Inc. (edgar:799694) Operating Cash Flow: -629942 USD Concept: fundies:OperatingCashFlow Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T16:59:57Z Snapshot: 01ed22ec72e8554fdd7a0cf6267970ad2e29aadefb79b7621f5e88b2b8dfdaa7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799694/explain?concept=fundies%3AOperatingCashFlow&period=2014-08-31&surface=latest&period_type=duration&start=2013-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -629942 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799694/000147124214000418/oclg-20140831.xml#652657 Filing: 000147124214000418 The citation records this snapshot. The page link may show a newer release later.	Unavailable The mapped spending value is negative, so its direction is unclear. Source Inspect Capital Expenditure Open source	Unavailable Capital expenditure has a negative mapped value; spending direction is unclear.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

128 filings · 899 latest values · 899 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000799694, 799694, edgar:799694

Also known as BESTNET COMMUNICATIONS CORP, Oncologix Tech Inc., WAVETECH INC, WAVETECH INTERNATIONAL INC

Oncologix Tech Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2014 2013-09-01 – 2014-08-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation